好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Comparing Psychopathologies Between Anorexia Nervosa-restricting (AN-R) and Binge-eating/Purging (AN-BP) Subtypes
General Neurology
P2 - Poster Session 2 (11:45 AM-12:45 PM)
7-006
To compare the psychopathological features of the AN-R and AN-BP subtypes among individuals with active anorexia nervosa (AN).
AN is a life-threatening eating disorder characterized by two clinical subtypes: restricting (AN-R) and binge-eating/purging (AN-BP).  
We administered the Eating Disorder Inventory (EDI-3) and Eating Disorder Examination Questionnaire (EDE-Q) to adult women currently ill with AN. Participants were classified by subtype (AN-R or AN-BP). Mann–Whitney U tests were conducted using RStudio to compare subscale and composite scores between subtypes.

Participants (n=54) had a mean age of 30.7 ± 11.1 years and a mean BMI of 16.7 ± 2.4. The AN-BP group (n = 29) exhibited significantly greater severity than the AN-R group (n = 25) on several EDI-3 subscales: Bulimia (12.69 ± 8.37 vs. 3.80 ± 5.69, p < 0.005), Personal Alienation (16.87 ± 6.32 vs. 12.45 ± 6.76, p = 0.049), Emotional Dysregulation (8.79 ± 6.21 vs. 5.97 ± 6.87, p = 0.044), and Maturity Fears (12.28 ± 6.27 vs. 9.32 ± 6.95 vs, p = 0.049); as well as two EDE-Q subscales: Restraint (3.79 ± 1.75 vs. 2.68 ± 1.76 ; p = 0.028) and Shape Concern (4.51 ± 1.39 vs. 3.45 ± 1.99, p = 0.041) (Mean ± SD; AB-BP vs. AN-R, respectively). 

Distinct psychopathological profiles differentiate the AN-R and AN-BP subtypes. Elevated impulsivity and affective symptoms in AN-BP warrant interventions addressing both impulse control and emotion regulation. These findings underscore the heterogeneity of AN and the importance of subtype-specific treatment approaches. Moreover, neurobiological mechanisms underlying AN may contribute to impaired cognitive flexibility and maladaptive behaviors. Therefore, rigorous neurobiological research is needed to identify novel approaches for improving treatment and outcomes.
Authors/Disclosures
Nhi N. Nguyen, MA
PRESENTER
Ms. Nguyen has nothing to disclose.
Kimberly Nguyen Ms. Nguyen has nothing to disclose.
Ha T. Nguyen, Data Reviewer Mrs. Nguyen has nothing to disclose.
Xia Wu, MBBS Mrs. Wu has nothing to disclose.
Blake Woodside (University of Toronto) No disclosure on file
Pei-an Betty Shih, PhD The institution of Dr. Shih has received research support from NIH.